908 Devices (MASS) Total Debt Growth (1y) (2021 - 2026)
908 Devices (MASS) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -0.50% |
| 10 | 908 Devices | 386.71 Mn | 285.18 Mn | 8.34 Mn | 141.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 141.53% |
| Dec 31, 2023 | -96.92% |
| Sep 30, 2023 | -95.15% |
| Jun 30, 2023 | -93.51% |
| Mar 31, 2023 | -93.74% |
| Dec 31, 2022 | 8.29% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 1.13% |